Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size
PIE II: Pharmacological Intervention in the Elderly II
Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD
|4||Not yet recruiting||
Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy
Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity
Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
Study to Characterize Atrial Fibrillation in CHF Patients Indicated for CRT
† Study has passed its completion date and status has not been verified in more than two years.